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Summary
Patterning of the anterior-posterior body axis of the
Drosophila embryo requires production of Nanos pro-
tein selectively in the posterior. Spatially restricted
Nanos synthesis is accomplished by translational re-
pression of unlocalized nanos mRNA together with
translational activation of posteriorly localized nanos.
Repression of unlocalized nanos mRNA is mediated
by a bipartite translational control element (TCE) in
its 30 untranslated region. TCE stem-loop II functions
during embryogenesis, through its interaction with the
Smaug repressor. Stem-loop III represses unlocal-
ized nanos mRNA during oogenesis, but trans-acting
factors that carry out this function have remained elu-
sive. Here we identify a Drosophila hnRNP, Glorund,
that interacts specifically with stem-loop III. We estab-
lish that the ability of the TCE to repress translation in
vivo reflects its ability to bind Glorund in vitro. These
data, together with the analysis of a glorund null mu-
tant, reveal a specific role for an hnRNP in repression
of nanos translation during oogenesis.
Introduction
The anterior-posterior body pattern of the early Dro-
sophila embryo is established by opposing gradients
of Bicoid (Bcd) and Nanos (Nos) proteins. These gra-
dients arise by translation of maternal bcd and nos
mRNAs that are localized at the anterior and posterior
poles of the embryo, respectively (reviewed in St John-
ston, 2005). While localization of bcdmRNA serves to re-
strict Bcd synthesis to the anterior, inefficient posterior
localization leaves the majority of nos mRNA distributed
throughout the embryo (Bergsten and Gavis, 1999).
Translational repression of this unlocalized RNA is es-
sential to prevent synthesis of Nos in the anterior of the
embryo, where Nos can suppress anterior development
by repressing translation ofbcd andbcd’s target,hunch-
back (Gavis and Lehmann, 1992, 1994; Wharton and
Struhl, 1989). Activation of nos translation requires asso-
ciation of nos with the posteriorly localized germ plasm,
ensuring that Nos synthesis is restricted to the posterior
(Gavis and Lehmann, 1994). Consequently, when nos
localization is prevented by mutation of oskar (osk) or
other genes that are required for germ plasm assembly,
nos translation is abolished (Gavis and Lehmann, 1994;
Wang et al., 1994).
Although nos and bcd mRNAs are employed in the
early embryo, their synthesis and localization occurs
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2003; St Johnston et al., 1989; Wang et al., 1994). Unlike
bcd, which is translationally inactive until fertilization
(Driever and Nu¨sslein-Volhard, 1988), nos is translated in
both the ovarian nurse cells where it is synthesized and
in the oocyte where it becomes localized to the germ
plasm (Forrest and Gavis, 2003; Wang et al., 1994). We
have previously shown that spatial control of nos trans-
lation during oogenesis is critical to achieve the re-
stricted distribution of Nos in the embryo (Forrest et al.,
2004). Translational repression of unlocalized nosmRNA
is mediated by a cis-acting translational control element
(TCE) in the nos 30 untranslated region (30UTR) (Dahanu-
kar and Wharton, 1996; Gavis et al., 1996a; Smibert et al.,
1996). A complex element, the TCE is composed of two
stem-loops, designated II and III, that have temporally
distinct functions and different modes of recognition
(Crucs et al., 2000; Forrest et al., 2004). Stem-loop II
mediates translational repression of unlocalized nos
RNA during early embryogenesis, whereas stem-loop
III mediates repression of unlocalizednos in late oocytes.
Thus far, a single protein, Smaug (Smg), has been
shown to interact with the TCE. Smg, which is present
only after fertilization, binds to unpaired nucleotides in
stem-loop II (the Smg recognition element; SRE), and
is required for repression of nos in the early embryo
(Dahanukar et al., 1999; Smibert et al., 1996, 1999). In
contrast, stem-loop III function in the ovary depends on
the double-stranded sequence and structure of the heli-
cal stem (Crucs et al., 2000; Forrest et al., 2004). The es-
sential, Smg-independent function of stem-loop III dur-
ing oogenesis suggests that this motif is the binding
site for an ovarian repressor of nos translation. A factor
that recognizes stem-loop III has yet to be identified,
however.
By using a biochemical approach to isolate TCE bind-
ing proteins, we have identified a previously uncharac-
terized Drosophila protein, Glorund (Glo), that belongs
to the heterogeneous nuclear ribonucleoprotein (hnRNP)
family. Members of the hnRNP family participate in all
aspects of nuclear and cytoplasmic RNA metabolism,
including mRNA processing, nuclear export, localiza-
tion, translation, and stability (reviewed in Dreyfuss
et al., 2002; Singh and Valcarcel, 2005). Although all
mRNAs are associated with hnRNPs and many hnRNPs
recognize numerous mRNAs, recent studies have iden-
tified roles for several hnRNPs in localization and/or
translational control of specific mRNAs. hnRNPs K and
E1, which repress translation of 15-lipoxygenase (LOX)
mRNA during erythrocyte differentiation, and hnRNP I,
which participates in localization of Vg1 and VegT
mRNAs in Xenopus oocytes, recognize specific primary
sequence motifs in the 30UTRs of their target mRNAs
that are required for regulation (Cote et al., 1999; Kress
et al., 2004; Ostareck et al., 1997). InDrosophila oocytes,
two hnRNP A/B family members, Squid and Hrp48/
Hrb27C, play roles in localization and translational con-
trol of gurken (grk) and osk mRNAs (Goodrich et al.,
2004; Huynh et al., 2004; Kelley, 1993; Norvell et al.,
1999, 2005; Yano et al., 2004). The sequence motifs in
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292Figure 1. Detection of p67 Binding Activity by
UV Crosslinking
(A) UV crosslinking of ovary or embryo extract
to 32P-labeled RNA probes detects a 67 kDa
protein (asterisk) that binds to the TCE but
not to the adjacent nos +20 or +3 localization
elements. The +20 element is recognized by
a distinct protein, p75 (Bergsten et al., 2001).
(B) UV crosslinking of embryo extract to 32P-
labeled TCE RNA in the absence (2) or pres-
ence of a 10-, 50-, or 100-fold molar excess of
unlabeled TCE, nos +20, or nos +3 competitor
RNA. The position of p67 is indicated by an
asterisk.
(C) UV crosslinking of purified MBP-p67 or
MBP-b-gal to 32P-labeled TCE RNA.the grk and osk mRNAs that are targeted by these
hnRNPs are not well defined, however.
Glo is most closely related to mammalian hnRNPs F
and H, whose RNA binding domains contain RNA recog-
nition motifs (RRM) that deviate from RRMs found in
the more common hnRNP A/B class (Honore et al., 1995;
Matunis et al., 1994). To our knowledge, Glo is the first
hnRNP F/H family member to be implicated in transla-
tional repression. We show that Glo interacts specifically
with a double-stranded motif in TCE stem-loop III and
that the ability of the TCE to bind Glo correlates with its
translational regulatory function. Furthermore, through
the analysis of a glo null mutation, we provide evidence
that Glo is required for translational repression of unlo-
calized nos mRNA in late oocytes. Thus, Glo acts prior
to Smg to establish the repressed state of nos during
oogenesis through its interaction with TCE stem-loop III.
Results
Identification of a TCE Binding Protein
Repression of unlocalized nos RNA in the early embryo
requires TCE stem-loop II and the Smg repressor (Daha-
nukar et al., 1999; Forrest et al., 2004; Smibert et al.,
1996). However, the ability of the TCE to repress trans-
lation in the ovary, which lacks Smg, and the Smg-in-
dependent requirement for TCE stem-loop III function
(Forrest et al., 2004) indicate that the TCE must be rec-
ognized by at least one other translational regulatory
factor. We took a biochemical approach, by using a UV
crosslinking assay, to search for TCE binding proteins
in both ovarian and embryonic extracts. Among several
proteins detected by this assay, one protein, with an Mr
of approximately 67 kDa (p67), binds only to the radio-
labeled TCE RNA substrate and not to RNAs encom-
passing other regions of the nos 30UTR (Figure 1A).
The specificity of p67 for the TCE was further confirmed
with a competition binding assay. The interaction of p67
with radiolabeled TCE RNA, detected by UV crosslink-
ing, was greatly diminished in the presence of excess
unlabeled TCE RNA but not by the addition of unlabeled
competitor RNAs representing other regions of the nos
30UTR (Figure 1B). Notably, p67 does not interact with
sequences from the nos 30UTR +20 element, a region ad-
jacent to the TCE that contains a second Smg binding
site (Gavis et al., 1996b; Smibert et al., 1996) (Figure 1).
Together, these results identify p67 as a specific TCE
binding factor.Purification and Identification of p67
p67 activity was purified from embryonic extract by frac-
tionation over Q sepharose, Reactive Blue 4 affinity
resin, and single-stranded DNA agarose (see Experi-
mental Procedures). Throughout purification, p67 bind-
ing activity was monitored by UV crosslinking to radio-
labeled TCE RNA and total protein was monitored by
SDS-PAGE. A band corresponding to p67 binding activity
was excised from a silver-stained gel and the contents
were analyzed by mass spectrometry. Six independent
peptides were identified that correspond to a 61.4 kDa
predicted protein encoded by the Drosophila gene
CG6946. This protein has sequence homology to two
members of the hnRNP protein family, hnRNP F and
hnRNP H (Figure 2A). hnRNP F and hnRNP H are highly
related proteins and the CG6946 product shows compa-
rable similarity to each, with 24% overall amino acid
identity/33% overall similarity to the human proteins.
hnRNP F and hnRNP H contain three repeats of an RNA
binding motif that resembles the conserved RRM found
in members of the hnRNP A/B subclass and other RNA
binding proteins (Honore et al., 1995; Matunis et al.,
1994). These quasi-RRM (q-RRM) motifs (Honore et al.,
1995) are more similar to each other than they are to the
RRM consensus sequence, and the homology between
the Drosophila and human proteins is highest in these
regions (42%–55% amino acid identity/62%–70% simi-
larity). While it lacks the C-terminal glycine-rich domain
shared by mammalian hnRNP F and hnRNP H, the Dro-
sophila protein has an extensive glycine- and aspara-
gine-rich region upstream of the third q-RRM (Figure 2A).
To confirm that CG6946 encodes p67, the CG6946
open reading frame was fused to Escherichia coli malt-
ose binding protein (MBP) and purified recombinant
protein was tested for its ability to bind to the nos
TCE. MBP-p67 interacts with the TCE in both UV cross-
linking and gel shift assays, whereas an MBP-b-galacto-
sidase (MBP-b-gal) fusion protein does not (Figures 1C
and 3B, and data not shown), demonstrating that bind-
ing is due to the presence of the CG6946 polypeptide.
Furthermore, MBP-p67 binds specifically to the TCE
and not to stem-loop structures in general (see Figure S1
in the Supplemental Data available with this article
online; also see Figure 3C). These results indicate that
the protein encoded by CG6946 represents p67 binding
activity. We have designated the CG6946 gene as glor-
und (glo) and p67 as Glo, after the evil dragon from J.R.R.
Tolkien’s The Silmarillion, who appeared before Smaug.
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To determine the significance of Glo’s interaction with
the nos TCE, we first investigated whether this interac-
Figure 2. Identification and Organization of glo
(A) ClustalW alignment of Glo (EST AT27789) to human hnRNPs H1
(GenBank accession number NP 005511) and F (GenBank accession
number NP 004957). Black boxes indicate amino acid identities; gray
boxes indicate amino acid similarities. The three quasi-RRM do-
mains are underlined in blue and the six peptides identified by
mass spectrometry are overscored in red.
(B) Genomic region surrounding the CG6946 (glo) gene. The organi-
zation of the glo transcript is shown, with the open reading frame
shaded and the quasi-RRMs highlighted in blue. Not shown are an
alternative transcript that lacks exon 4 and encodes a C-terminally
truncated protein and a second transcript with an alternative 50
exon that does not alter the open reading frame (FlyBase). The
neighboring gene, CG14724, which encodes mitochondrial cyto-
chrome oxidase Va (CoVa), is transcribed divergently. The position
of the l(3)S011046 P{lacW} element insertion (filled arrowhead) and
the extent of the glo162x deletion produced by imprecise excision
of this element (brackets; see Experimental Procedures) are indi-
cated. The lethality and maternal affect phenotypes of both
l(3)S011046 and glo162x are rescued by a single copy of either the
g-glo or g-gloS transgene, indicating the lethality is not due to dis-
ruption of the adjacent CoVa gene.tion involves stem-loop II, stem-loop III, or both. A gel
mobility shift assay showed that Glo binds with similar
affinity to transcripts encompassing either the entire TCE
(Kd = 250 nM) or TCE stem-loop III alone (Kd = 290 nM)
(Figures 3A, 3B, 3D, and 3E). By contrast, Glo does not
interact significantly with TCE stem-loop II (Kd at least
10-fold higher; Figures 3C and 3E).
The ability of the TCE to function when stem-loops II
and III are separated by a 52-nucleotide spacer (Crucs
et al., 2000) and the Smg-independent requirement for
stem-loop III function during oogenesis (Forrest et al.,
2004) predict that recognition of stem-loop III by a candi-
date regulatory factor(s) should not require Smg. Con-
sistent with this prediction, Smg and Glo bind to the in-
tact TCE independently of each other in a gel mobility
shift assay. Furthermore, each protein can supershift
a TCE-protein complex containing the other (Figure 4A).
Mutation of the Smg binding site in TCE stem-loop II
(TCE:SRE2) eliminates the supershift produced by the
addition of Smg, indicating that Smg shifts the TCE-Glo
complex through its interaction with the SRE and not
through a direct interaction with Glo (Figure 4B). Thus,
Glo and Smg can bind to the TCE simultaneously.
Glo Binding In Vitro Correlates with TCE
Function In Vivo
Previous mutational analysis of stem-loop III revealed
that both the sequence and structure of the helical
stem, but not the terminal loop, are critical for TCE func-
tion in vivo (Crucs et al., 2000). To determine whether the
requirements for recognition of stem-loop III by Glo are
the same or different from the requirements for TCE
function, we analyzed the effect of TCE stem-loop III mu-
tations on Glo binding in a gel mobility shift assay. Re-
placement of the loop sequence by a UUCG tetraloop
(IIIT-loop) has little effect on Glo binding (Kd = 200 nM
versus Kd = 290 nM for TCEIII; Figures 5A, 5B, and 5I),
consistent with the ability of the TCE to tolerate this mu-
tation in vivo (Crucs et al., 2000). Similarly, Glo binding is
not diminished by mutations that change the unpaired U
residues (data not shown) or by deletion of the proximal
portion of the stem (IIIDprox, Kd = 240 nM; Figures 5C
and 5I). Neither of these mutations affects TCE function
in vivo (Crucs et al., 2000). By contrast, binding to stem-
loop III is reduced more than 10-fold by two mutations
that target the distal portion of the helical stem: IIIGC,
which disrupts both the sequence and base pairing of
the distal portion of the helical stem, and the compensa-
tory mutation IIIGC/GC (Figures 5D, 5E, and 5I). Both of
these mutations abolish TCE function in the ovary (Crucs
et al., 2000; Forrest et al., 2004).
Surprisingly, the IIIA mutation, which behaves simi-
larly to IIIGC and IIIGC/GC in vivo and disrupts TCE func-
tion in the ovary (Crucs et al., 2000; Forrest et al., 2004),
is less deleterious than these mutations to Glo binding in
vitro (Kd = 370 nM; Figures 5F and 5J). This behavior of
the IIIA mutation, which eliminates only a subset of the
base pairs that comprise stem III, suggests that it is
less effective at disrupting TCE structure, and conse-
quently Glo binding, in vitro than in vivo. We tested
this hypothesis by combining the IIIA mutation with
a second mutation that eliminates base pairing in the
proximal portion of the stem, IIIprox, to further destabi-
lize stem III. Whereas the IIIprox mutation on its own
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(A) Structure of the D. melanogaster nos TCE with stems designated by Roman numerals.
(B–D) Gel mobility shift assay for interaction of MBP-Glo (MBP-p67) with 32P-labeled RNA probes for the intact TCE (B), TCE stem-loop II (C), or TCE
stem-loop III (D). Binding reactions contained the same molar amount of input RNA and 0 (2) or identical increasing concentrations of MBP-Glo.
(E) Binding data were fitted to the Hill equation for determination of relative Kds. F represents fraction of RNA bound.does not decrease affinity for Glo (Kd = 250 nM; Figures
5G and 5J), the double mutation, IIIAprox, reduces affin-
ity for Glo by more than 10-fold (Figures 5H and 5J).
These results indicate a structural requirement for rec-
ognition of stem-loop III by Glo.
Taken together, data presented here indicate that
Glo recognizes the double-stranded UA-rich motif in
the distal half of TCE stem-loop III that is required for
TCE function in the ovary (Crucs et al., 2000; Forrest
et al., 2004). The evidence that Glo binding is disrupted
by mutations that eliminate TCE function in vivo, but not
by mutations that retain in vivo activity, provides strong
support for Glo as a stem-loop III-dependent repressor
of nos translation.
Distribution of Glo in Ovaries and Embryos
In situ hybridization to glo RNA shows that glo is ex-
pressed in both somatic and germline cells of the ovary
and maternally deposited glo RNA is present uniformly
within the early embryo (data not shown). To investigate
the distribution of Glo protein at these stages, we gener-
ated monoclonal antibodies against the Glo polypep-
tide. These antibodies recognize a single protein with
an apparent molecular weight of 67 kDa in extracts pre-
pared from ovaries and early embryos (Figure 6A). As re-vealed by immunofluorescence with monoclonal anti-
body 5B7, Glo protein is present in the nuclei and
cytoplasm of the ovarian nurse cells and in the somatic
follicle cells that surround the nurse cells and oocyte.
In addition, lower levels of Glo are detected in the oocyte
(Figures 6B and 6C). Specificity of the antibody for Glo is
demonstrated by the lack of immunoreactivity in the
ovarian nurse cells, oocytes, and preblastoderm em-
bryos from females with glo mutant germline clones (de-
scribed below; Figures 6A, 6D, 6E, and 6F). Like gloRNA,
Glo protein is distributed uniformly throughout the pre-
blastoderm embryo (Figure 6G). While glo RNA and pro-
tein are both present in the newly formed germ cells at
the posterior of the embryo, their levels are reduced rel-
ative to the neighboring somatic cells (Figure 6H and
data not shown). As embryogenesis proceeds, glo RNA
and protein become progressively restricted to the cen-
tral nervous system (data not shown).
Generation of a Null glo Allele
To assess the function of glo in development and to de-
termine whether Glo regulates nos RNA in vivo, we gen-
erated a glo null mutation starting with a lethal P element
insertion in the glo 50UTR, l(3)S011046 (Figure 2B). Mobi-
lization of the P element produced an approximatelyFigure 4. In Vitro Formation of a Complex
Containing the TCE, Glo, and Smg
The ability of MBP-Glo and MBP-SmgC (see
Experimental Procedures) to bind to the
TCE simultaneously was tested by gel mobil-
ity shift assay.
(A) Binding reactions containing a constant
amount (500 ng) of MBP-Glo and 32P-labeled
TCE RNA were challenged by the addition
of an increasing amount (0–500 ng) of MBP-
SmgC (left half). Similarly, the amount of
MBP-SmgC was kept constant at 500 ng and
0–500 ng of MBP-Glo was added (right half).
Reactions without any protein added are indi-
cated as (2). In each case, the TCE-protein complex was supershifted by the addition of the second protein. The intermediate complex formed
when MBP-SmgC is added to the TCE-Glo complex at low concentration is also formed by MBP-SmgC and the TCE in the absence of Glo (not
shown) and may be due to a less abundant but potentially higher affinity MBP-SmgC degradation product that copurifies with full-length MBP-
SmgC.
(B) Experiment similar to (A) with 32P-labeled TCE:SRE– RNA. MBP-SmgC does not bind to the TCE:SRE– RNA, nor does it supershift the complex
of TCE:SRE– with MBP-Glo.
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295Figure 5. Identification of the Glo Recognition Element
(A–H) Gel mobility shift assay for binding of MBP-Glo to 32P-labeled TCE stem-loop III wild-type (A) or mutant RNAs: (B) IIIT-loop, (C) IIIDprox,
(D) IIIGC, (E) IIIGC/GC, (F) IIIA, (G) IIIprox, and (H) IIIAprox. Mutations were generated based on the analysis of Crucs et al. (2000), which shows
that TCE function in vivo requires a specific double-stranded recognition motif in stem-loop III. All binding reactions contained the same amount
of input RNA and the same increasing concentrations of MBP-Glo, conditions identical to those used in Figure 3.
(I and J) Binding data were fitted to the Hill equation for determination of relative Kds. Data for the wild-type TCEIII obtained from the experiment
shown in (A) were plotted in both graphs. The Kd for TCEIII binding determined in this experiment (290 nM) is identical to the Kd determined in-
dependently in the experiment shown in Figure 3B. F represents fraction of RNA bound.1.1 kb deletion beginning 576 bp upstream and ending
512 bp downstream of the translation start codon. The
deletion removes the glo transcription start site and 50
flanking region, the first and second exons, and part of
the second intron for all predicted splice forms. Like
the P element insertion, this allele, glo162x, is lethal. Be-cause glo162x produces no detectable Glo protein (Fig-
ure 6A), it constitutes a molecular null allele.
Because homozygous glo mutant animals are not via-
ble, we investigated the maternal function of glo by gen-
erating homozygous glo mutant germline clones in fe-
males heterozygous for either of the two glo alleles.
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(A) Immunoblot analysis of Glo protein in 0–1.5 hr wild-type (WT) or glo162x embryos. Duplicate samples are shown for each. Snf serves as a load-
ing control. Identical results were obtained by using anti-Glo monoclonal antibody 5B7 (shown) and anti-Glo polyclonal mouse antiserum. Trace
levels of Glo in glo162x embryos result from contamination by zygotic glo expression in a small number of embryos within the pool used to prepare
extract, as confirmed by immunostaining of embryos from the same pool.
(B–E) Anti-Glo (red) immunofluorescence in egg chambers. Glo is detected in the nuclei and cytoplasm of the nurse cells, oocyte, and somatic
follicle cells from wild-type egg chambers (B and C). In ovaries from glo162x germline clones, Glo is detected only in the follicle cells (D and E). The
actin cytoskeleton is visualized in green and DNA in blue.
(F–H) Anti-Glo immunohistochemistry in embryos. Maternal Glo protein is distributed uniformly in wild-type preblastoderm embryos (G) but
cannot be detected in preblastoderm embryos from glo162x germline clones (F). In blastoderm embryos, Glo accumulation is decreased in
pole cells (H).Ovaries derived from these germline clones are desig-
nated hereafter as glo mutant ovaries. Over 60% of eggs
produced by females with glo162x mutant ovaries (desig-
nated hereafter as glo mutant eggs or embryos) fail to
develop beyond blastoderm stages. Between 10% and
20% of these display gross morphological defects, in-
cluding abnormal dorsal appendages, collapsed ap-
pearance, or shortened egg length and are frequently
unfertilized. Similarly pleiotropic phenotypes are pro-
duced by mutations in hrp48/hrb27C and smg, suggest-
ing that regulation of multiple target mRNAs is a common
feature.
Approximately 25% of eggs from glo162x mutant ova-
ries develop to hatching, while a small and variable frac-
tion (5%–10%) show defects in anterior-posterior pat-
terning, including loss of anterior structures, loss of
abdominal segments, and bicaudal phenotypes. Em-
bryos produced by females with gloS011046 mutant germ-
line clones show the same range and frequency of phe-
notypes displayed by glo162x mutant embryos and these
phenotypes are reverted by precise excision of the P el-
ement. Furthermore, all of the maternal effect pheno-
types and the lethality of both mutant alleles are rescued
by a single copy of a genomic transgene containing only
the glo transcription unit (Figure 2B). Thus, the observed
phenotypes result exclusively from the gloS011046 P ele-
ment insertion or the glo162x deletion.
Mislocalization of nos and osk in glo Mutant
Embryos
The anterior defects exhibited by glo mutant embryos
are similar to those produced when nos is inappropri-
ately translated in the anterior of the embryo. Such inap-propriate translation can result either from ectopic local-
ization of nos RNA at the anterior of the embryo,
derepression of unlocalized nos RNA by mutations in
the TCE, or both (Crucs et al., 2000; Gavis and Lehmann,
1992). Likewise, loss of abdominal segments can result
from failure to produce Nos protein at the posterior, due
to defects in either posterior localization of nos RNA or
translational activation of the localized RNA (Bergsten
and Gavis, 1999; Gavis and Lehmann, 1994). In situ hy-
bridization and immunostaining experiments revealed
aberrant distributions of nos RNA and protein, including
ectopic localization at the anterior and decreased or ab-
sent posterior localization at low and variable frequency
(2%–10%) that is similar to the penetrance of anterior-
posterior patterning defects (Figure S2). In some em-
bryos, both anterior and posterior localization defects
occurred simultaneously. Aberrant nos localization
may thus account for the observed anterior-posterior
patterning defects.
The effect of glo mutations on nos localization is likely
to be indirect, however, because localization and regu-
lation of osk RNA are perturbed similarly to nos
(Figure S3). Such defects in osk localization have previ-
ously been shown to produce corresponding defects in
nos localization through their effect on germplasm as-
sembly (Ephrussi et al., 1991; Ephrussi and Lehmann,
1992; Kim-Ha et al., 1991). We have not detected any in-
teraction of Glo with osk 50 or 30UTR sequences, nor with
Osk protein. Furthermore, removal of the first osk intron,
which is required for osk localization (Hachet and Eph-
russi, 2004), is not affected in glo mutant germline
clones (data not shown). These results suggest that
the effect of glo loss on osk is also indirect. Additional
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stream of osk.
Glo Represses Translation of Unlocalized nosmRNA
in Late Oocytes
The specific interaction of Glo with TCE stem-loop III
and the correlation between mutations that disrupt Glo
binding in vitro and TCE function in vivo support a direct
role for Glo in translational regulation of nos. Because
TCE stem-loop III mediates translational repression of
unlocalized nos RNA in late oocytes (Forrest et al.,
2004), we investigated whether Glo participates in this
aspect of TCE function. We took advantage of a gfp-
nos transgene that serves as a faithful reporter for nos
translation in the ovary (Forrest et al., 2004) to examine
the effect of eliminating glo on translation of unlocalized
nos RNA in late stage oocytes. This transgene is ex-
pressed comparably to endogenous nos and completely
rescues the nos mutant phenotype (Forrest et al., 2004).
nos RNA is synthesized in the nurse cells that are con-
nected to the anterior of the oocyte and is translated
there during midoogenesis (stages 5–10) (Forrest et al.,
2004; Wang et al., 1994). At the end of stage 10, when
the nurse cells contract and extrude their cytoplasm
into the oocyte (nurse cell ‘‘dumping’’), this actively
translating nos RNA enters the oocyte where it becomes
translationally repressed. Translation is activated again
only upon the subsequent localization of nos to the oo-
cyte posterior. Nos protein that enters the ooctye from
the nurse cells is degraded and undetectable by late
oogenesis (stages 13–14) (Forrest et al., 2004). Conse-
quently, in stage 14 oocytes from females carrying two
copies of the gfp-nos transgene (23 gfp-nos), GFP-Nos
protein is detected only at the posterior pole (Figure 7A).
By contrast, GFP-Nos is readily detected throughout
the ooplasm of stage 14 oocytes from glo162x germline
clones, even when these clones are generated in fe-
males with half the gfp-nos dosage (13 gfp-nos; Fig-
ure 7B). Notably, the effect on gfp-nos produced by
eliminating glo is similar to the effect produced by elim-
inating the TCE, as shown previously for the gfp-nos-
tub30UTR transgene (Forrest et al., 2004). In the latter
case, unregulated translation of gfp-nos-tub30UTRRNA,
which bears a-tubulin 30UTR sequences in place of the
nos 30UTR, results in accumulation of GFP-Nos through-
out the late oocyte. Together, these results support
a role for glo in translational repression of unlocalized
nos RNA in late oocytes.
Efforts to generate chromosomes for production of
germline clones doubly mutant for glo and osk proved
unsuccessful. Therefore, to confirm that loss of maternal
glo function results in derepression of unlocalized nos
RNA independent of any effect on the osk localization
pathway, we took advantage of a nos transgene, nos-
tub:TCEU51A, whose activity is osk independent. In
this transgene, which encodes a functional HA-tagged
Nos protein, the nos 30UTR is replaced by a-tubulin
30UTR sequences into which a mutant TCE is inserted
(Crucs et al., 2000). The TCEU51A mutation does not af-
fect the translational repression function of the TCE but
eliminates the weak RNA localization of the nos +1 local-
ization signal element, which overlaps the TCE. Thus,
nos-tub:TCEU51A RNA is not recognized by the osk-de-
pendent localization machinery and remains completelyunlocalized and translationally repressed (Crucs et al.,
2000).
Because Nos protein encoded by the transgene is HA
tagged, production of Nos exclusively from nos-tub
TCEU51A RNA can be compared in late stage oocytes
from transgenic females with wild-type or glo162x mutant
germlines. As monitored by immunoblotting, HA-Nos
protein is not detected in stage 14 oocytes from nos-
tub:TCEU51A females that are wild-type for glo. By con-
trast, HA-Nos protein is readily detected in stage 14
oocytes from nos-tub:TCEU51A females with glo162x
germline clones (Figure 7C). Furthermore, the elevated
GFP-Nos and HA-Nos levels in glo mutant oocytes do
not reflect an effect of glo on nosmRNA synthesis or sta-
bility (Figure 7D). Together, these results provide strong
evidence that glo is required for repression of unlocal-
ized nos mRNA in late oocytes.
Discussion
We have identified and characterized a Drosophila
hnRNP protein, Glo, that interacts with the region of the
nos TCE responsible for translational repression of unlo-
calized nos mRNA during oogenesis. Several lines of ev-
idence establish Glo as a repressor of nos translation.
First, binding of Glo to the double-stranded UA-rich mo-
tif of TCE stem-loop III in vitro correlates with the ability
of this element to repress translation in vivo. Second,
Figure 7. Glo Represses nos mRNA Translation in the Ovary
(A) Direct visualization of GFP-Nos (green) in a stage 14 oocyte from
a female carrying two copies of the gfp-nos transgene.
(B) GFP-Nos in a stage 14 oocyte derived from a glo162x germline
clone induced in a female carrying a single copy of the gfp-nos trans-
gene. The actin cytoskeleton is labeled in red with phalloidin.
(C) Immunoblot analysis of HA-Nos protein in extracts of stage 14
egg chambers from females heterozygous for glo162x that carry
two copies of the nos-tub:TCEU51A transgene (glo2/+) or from fe-
males with glo162x germline clones that carry a single copy of the
nos-tub:TCEU51A transgene (glo2/glo2). The anti-HA antibody
used to detect HA-Nos crossreacts with a protein that comigrates
with HA-Nos, as observed previously (Forrest et al., 2004). Snf pro-
tein was monitored as a loading control.
(D) Northern analysis of nos RNA in wild-type (WT) and glo162x (glo2/
glo2) germline clone ovaries. rp49 RNA was monitored as a loading
control.
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shows increased accumulation of GFP-Nos in late oo-
cytes. Finally, loss of glo results in derepression of unlo-
calized, translationally silent nos RNA in late oocytes.
The translational activity of nosRNA during oogenesis
is both spatially and temporally dynamic. nos is trans-
lated first in the nurse cells, but becomes repressed in
the oocyte after nurse cell dumping (Forrest et al.,
2004). The rapid inactivation of nos translation upon en-
try into the oocyte has been proposed to occur by a
mechanism that blocks translation downstream of the
initiation step (Clark et al., 2000). The identification of
Glo will now facilitate investigation of this mechanism.
As Glo is present in both the nurse cells and oocyte, the
ability of Glo to interact with nos or repress its translation
must be largely restricted to the oocyte. Evidence that
Nos protein produced in nurse cells is targeted for degra-
dation in the oocyte (Forrest et al., 2004) suggests that
there are significant physiologic differences between
the nurse cells and oocyte that can affect protein behav-
ior. Thus, Glo could be negatively regulated by a nurse
cell-specific cofactor or modification event, or positively
regulated by an oocyte-specific factor or modification.
Following fertilization, repression of nos translation is
mediated primarily by the interaction of Smg with stem-
loop II (Forrest et al., 2004). Because misexpression of
Smg in the female germline severely disrupts oogenesis
(Semotok et al., 2005; N. Jeurkar and E.R.G., unpub-
lished data), Smg cannot fulfill the role of an ovarian re-
pressor of nos translation. At the same time, although
Glo is normally present in the early embryo, derepres-
sion of nos RNA in smg mutants indicates that Glo can-
not substitute for Smg during embryogenesis. Thus, Glo
and Smg fulfill temporally distinct roles in nos regulation.
The minor requirement observed for stem-loop III in em-
bryonic repression (Forrest et al., 2004) may, however,
reflect a role for Glo at the beginning of embryogenesis
while Smg is accumulating. The ability of Glo and Smg to
bind to the TCE simultaneously would therefore ensure
that repression is maintained across the transition
from oogenesis to embryogenesis.
The translational activity of posteriorly localized nos
RNA requires that repression by Glo and Smg is allevi-
ated at the posterior of the oocyte and embryo, respec-
tively. However, Glo, like Smg (Dahanukar et al., 1999;
Smibert et al., 1999), is uniformly distributed. Thus, both
proteins must be prevented from functioning at the pos-
terior pole. Genetic evidence that binding of localization
factors and translational repressors to nos RNA is mutu-
ally exclusive (Bergsten and Gavis, 1999) suggests that
localization factors at the posterior may compete with
Glo and Smg for binding to the nos 30UTR. Alternatively,
factors at the posterior pole may inactivate the repres-
sors locally by posttranslational modification.
The effect of eliminating glo is less severe than antic-
ipated from our previous analysis of the effect of TCE
stem-loop III mutations that eliminate Glo binding
(Crucs et al., 2000). For example, approximately 25%
of glo mutant embryos develop and hatch as larvae,
whereas all embryos produced by females carrying the
nos-tub:TCEIIIA transgene die with anterior defects.
Thus, it is possible that a second ovarian factor, which
recognizes TCE stem-loop III similarly to Glo, can par-
tially compensate for loss of glo function. Given thatthe nos-tub:TCEIIIA transgene lacks all nos 30UTR se-
quences outside of the TCE (Crucs et al., 2000), we favor
the alternative explanation that additional factors bind-
ing to other regions of the nos 30UTR can contribute
to repression during oogenesis. Attempts to identify
such regulatory sequences and factors are currently in
progress.
Glo is the closest Drosophila homolog to mammalian
hnRNPs F and H. A second Drosophila protein, Fusilli
(Fus), contains RNA binding domains that are more dis-
tantly related to hnRNPs F and H and even more dis-
tantly related to Glo, but show greatest similarity to a
human protein of unknown function (Wakabayashi-Ito
et al., 2001). Thus, hnRNPs F and H appear to be repre-
sented inDrosophila by a single protein. Members of the
F/H family have been implicated as general splicing fac-
tors through their interaction with the nuclear cap bind-
ing proteins and as regulators of alternative splicing in
mammalian neuronal cells (Chou et al., 1999; Gamberi
et al., 1997). An hnRNP F/H-related protein, guanine-
rich sequence factor 1 (GRSF-1), stimulates translation
of influenza virus-encoded mRNAs by binding to se-
quences in their 50UTRs (Kash et al., 2002). To our knowl-
edge, Glo is the first hnRNP F/H family member to be
identified as a translational repressor, however. The
ability to recognize the double-stranded UA motif in
TCE stem-loop III sets Glo apart from its mammalian
splicing counterparts, which bind preferentially to
poly(rG) sequences (Caputi and Zahler, 2001; Matunis
et al., 1994). In addition, Glo differs from the mammalian
proteins by the insertion of a glycine- and asparagine-
rich domain between the second and third q-RRMs.
These differences may reflect the unique acquisition by
Glo of functions such as translational repression. It will
therefore be of interest to determine whether the mam-
malian proteins participate in translational control in ad-
dition to splicing and, likewise, whether Glo also func-
tions as a splicing factor.
Like Hrp48/Hrb27C, which was first identified as a
splicing regulator and subsequently shown to regulate
both localization and translation of grk and osk mRNAs
(Goodrich et al., 2004; Hammond et al., 1997; Huynh
et al., 2004; Yano et al., 2004), Glo may serve multiple
functions. The pleiotropy of the glo mutant phenotype,
including its zygotic lethality, suggests that glo acts at
different developmental stages to regulate RNAs in ad-
dition to nos. Expression of Glo in the central nervous
system (CNS) at late stages of embryogenesis is partic-
ularly intriguing in light of increasing evidence for trans-
lational control in neuronal development and synaptic
function (reviewed in Martin, 2004; reviewed in Piper
and Holt, 2004). Furthermore, we have recently shown
that the TCE can mediate translational repression in
subsets of cells in the CNS and this repression is Smg in-
dependent (Clark et al., 2002). Glo is therefore a good
candidate to mediate repression of RNAs with TCE-
like motifs in the CNS.
Experimental Procedures
Purification of Glo
Throughout purification, p67 binding activity was monitored by UV
crosslinking to 32P-labeled TCE RNA. The starting material for puri-
fication was 50 g of OregonR embryos from overnight collections,
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liquid N2. Crude extract was prepared as previously described
(Bergsten et al., 2001), with the addition of 10% glycerol to the lysis
buffer. The extract (approximately 4 g total protein) was diluted to
15 mg/ml with buffer C (25 mM HEPES [pH 7.9], 0.5 mM EDTA,
1 mM DTT, 10% glycerol, 0.5 mM PMSF) supplemented with
100 mM KCl (buffer C/100 mM KCl) and loaded onto a 30 ml Q Se-
pharose Fast Flow column (Amersham Pharmacia Biotech) equili-
brated with buffer C/100 mM KCl. The column was washed with
1.5 liter buffer C/150 mM KCl and p67 activity was eluted with 90
ml buffer C/200 mM KCl. The eluate was mixed with 3 ml Reactive
Blue 4 beads (Sigma) equilibrated with buffer C/200 mM KCl for 30
min after which the mixture was packed into a column. After washing
with 150 ml of buffer C/200 mM KCl, p67 activity was eluted with 9 ml
of buffer C/600 mM KCl. The eluate from the Blue 4 column was then
diluted by adding 27 ml buffer C before being mixed with 0.5 ml
single-stranded DNA agarose (Amersham Pharmacia Biotech) for
30 min. The mixture was then packed into a column and washed
with 20 ml buffer C/150 mM KCl. p67 activity was eluted with 1.5
ml buffer C/300 mM KCl and the eluate was concentrated with
a Microcon YM-10 spin column (Millipore) to a final volume of 140 ml.
Purified protein was resolved by electrophoresis on an 8% SDS-
polyacrylamide gel and a band corresponding to p67 binding activity
was detected by silver staining and excised from the gel. Sequence
analysis was performed at the Harvard Microchemistry Facility by
microcapillary reverse-phase HPLC nano-electrospray tandem
mass spectrometry on a Finnegan LCQ DECA quadrupole ion trap
mass spectrometer.
Production of Recombinant MBP-Glo, MBP-b-gal,
and MBP-SmgC
Full-length Glo (EST clone AT27789) or amino acids 583–860 of Smg
were fused to the C terminus of maltose binding protein (MBP) in the
pMAL-c2 vector (New England Biolabs). MBP-b-gal is produced
from pMAL-c2 vector itself. MBP-Glo, MBP-b-gal, and MBP-SmgC
proteins were expressed in E. coli and purified on amylose/agarose
resin (New England Biolabs) according to the manufacturer. For gen-
eration of monoclonal anti-Glo antibodies (Princeton University
Monoclonal Antibody Facility), the Glo polypeptide was cleaved
from MBP with Factor Xa (gift of F. Hughson), purified by SDS-
PAGE, and recovered by electroelution.
In Vitro RNA Binding Assays
Plasmids for in vitro transcription of the +20 and +3 localization ele-
ments have been previously described (Bergsten et al., 2001). For in
vitro transcription of ms2 stem-loops, an EcoRI-BamHI fragment
from pSL-MS2-6 (Bertrand et al., 1998) encoding six ms2 stem-
loops was end filled and inserted into the SmaI site of pBS-SKDKP,
a modified version of pBS-SK(+) (Stratagene) in which the polylinker
sequences between the KpnI and PstI sites have been deleted. Wild-
type TCE and TCE:SRE– sequences were also inserted into the SmaI
site of pBS-SKDKP. Individual TCE stem-loops and mutant deriva-
tives were cloned similarly as annealed oligonucleotides. Plasmids
were linearized with BamHI and RNAs were transcribed as previ-
ously described (Bergsten et al., 2001). Prior to use, radiolabeled
RNAs were heated to 65ºC for 5 min, and then slowly cooled to
room temperature.
UV crosslinking assays were performed according to Bergsten
et al. (2001). For gel mobility shift assays, recombinant proteins
were incubated with 3.5 fmol of 32P-labeled RNA in binding buffer
(10 mM HEPES [pH 7.9], 100 mM KCl, 1 mM DTT, 1 mg/ml tRNA,
0.1 mg/ml poly[rU], 2 mM MgCl2, 5% glycerol) and 40 units of RNasin
in a total volume of 15 ml for 10 min on ice, then electrophoresed at
4ºC on 6% polyacrylamide gels (29:1 acrylamide:bisacrylamide)
with 13 TBE. The same preparation of MBP-Glo was used for all ex-
periments shown. Dried gels were quantitated by phosphorimaging
(Molecular Dynamics) and binding data were fitted to the Hill equa-
tion with Prism4.0 (Graphpad Software).
Genetic Analysis
Fly stock l(3)S011046, carrying a P{lacW} insertion in gene CG6946
(Caggese, 2000; Deak et al., 1997), was obtained from the Szeged
Stock Center. Initial attempts to excise the P element revealed
thatw10% of third chromosomes in this stock carry a second lethal
mutation. An isogenized third chromosome exhibiting only thelethality associated with the P{lacW} at the CG6946 locus was
used for all subsequent manipulations. Following excision of the
P{lacW}, 159 lines were recovered that complemented the lethality
of l(3)S011046. An additional 33 lines were recovered that failed to
complement l(3)S011046. All 33 were homozygous lethal and could
be complemented by a glo transgene. Twenty-one of these lethal ex-
cision lines were analyzed by Southern blotting. One line, glo162x,
was identified as lacking all P element sequences and part of the
CG6946 coding region. The endpoints of the glo162x deletion were
determined by PCR. The glo162x mutation was recombined onto a
P{neoFRT}82B chromosome (Bloomington Stock Center) and germ-
line clones were induced by the dominant female sterile method
(Chou et al., 1993). For analysis of maternal glo function, females
with glo162x germline clones were mated to wild-type males.
Construction of Transgenes and Transgenic Lines
Thegfp-nosandnos-tub:TCEU51A transgenes have been previously
described (Crucs et al., 2000; Forrest et al., 2004). Glo transgenes
were generated in the CaSpeR P element vector (Pirrotta, 1988)
and contained glo genomic sequences isolated from BAC clone
BACR03D22 (Berkeley Drosophila Genome Project) as a 5.6 kb PstI
fragment (g-glo) or a 4.5 kb BglII-PvuII fragment (g-gloS). Multiple in-
dependent lines were generated for each transgene by P element-
mediated germline transformation of y w67c32 (Lindsley and Zimm,
1992).
Northern and Immunoblot Analysis
Extraction of total RNA and Northern blotting was carried out as de-
scribed in Bergsten and Gavis (1999). Preparation of ovary and em-
bryo extracts and immunoblotting with anti-HA and anti-Snf anti-
bodies followed the procedures of Forrest et al. (2004) except that
nitrocellulose membrane was used. Anti-Glo monoclonal antibody
5B7 was used at 1:750.
In Situ Hybridization, Immunostaining, and GFP Imaging
In situ hybridization with digoxigenin-labeled RNA probes for nos
and osk was performed according to Gavis and Lehmann (1992). Im-
munohistochemistry was performed according to Duchow et al.
(2005), with 1:50 monoclonal anti-Glo (5B7), 1:2000 rabbit anti-Nos
(gift of A. Nakamura), or 1:4000 anti-Osk (gift of A. Ephrussi). For
anti-Glo immunofluorescence, ovaries were fixed for 20 min in
a 1:5 mixture of 4% paraformaldehyde/PBS:heptane, and rinsed
three times for 10 min in PBST (PBS/0.03% Triton X-100). Ovaries
were blocked for 1 hr in PBST/3% BSA, followed by 1 hr incubation
in a 1:250 dilution of monoclonal anti-Glo in PBST/3% BSA. The ova-
ries were washed three times for 10 min in PBST, then incubated in
the dark for 30 min with 1:1000 AlexaFluor 568-conjugated anti-
mouse secondary (Molecular Probes), 1 mg/ml final concentration
Hoechst (Molecular Probes), and 1:1000 rhodamine-phalloidin or
Oregon Green 488-phalloidin (Molecular Probes) in PBST. Stained
ovaries were washed once for 10 min in PBST, twice for 10 min in
PBS, and mounted in PBS. GFP-Nos was visualized as previously
described (Forrest et al., 2004). Fluorescence images were captured
with a Zeiss LSM 510 confocal microscope.
Supplemental Data
Supplemental Data include three figures and are available at http://
www.developmentalcell.com/cgi/content/full/10/3/291/DC1/.
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